| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
26,652 |
18,621 |
$2.90M |
| 98960 |
|
494 |
164 |
$17K |
| 3078F |
|
3,220 |
2,469 |
$455.00 |
| 3074F |
|
3,999 |
2,988 |
$455.00 |
| 3079F |
|
2,476 |
1,875 |
$330.00 |
| 3077F |
|
724 |
578 |
$195.00 |
| 3075F |
|
1,197 |
961 |
$195.00 |
| 3080F |
|
306 |
260 |
$90.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,233 |
12,498 |
$83.06 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,002 |
4,996 |
$39.72 |
| 82948 |
|
879 |
621 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
90 |
82 |
$0.00 |
| 81025 |
|
1,342 |
1,059 |
$0.00 |
| 81002 |
|
209 |
174 |
$0.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
454 |
149 |
$0.00 |
| 99173 |
|
57 |
48 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
163 |
132 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
15 |
13 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14 |
12 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
909 |
525 |
$0.00 |
| 3008F |
|
9,194 |
6,587 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
12 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
486 |
376 |
$0.00 |
| J1094 |
Injection, dexamethasone acetate, 1 mg |
324 |
261 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
272 |
197 |
$0.00 |
| 4000F |
|
99 |
82 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
101 |
83 |
$0.00 |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
341 |
285 |
$0.00 |
| 82962 |
|
30 |
25 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
56 |
37 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
184 |
159 |
$0.00 |